MUMBAI, Sept 29 (Reuters) - India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 ...

While there isn’t much on the market’s surface, experts point to undercurrents — with pharmaceuticals, AI sector companies ...

Indian stock markets faced a significant downturn as Sensex and Nifty indices dropped due to heightened crude oil prices and ...

Varmora Granito Share Price: Varmora Granito shares got listed on September 29 at an issue price of Rs 148, following 1.60x ...

Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 29th September 2026.

Indian pharma stocks rose after the US exempted select specialty drugs from India from ad-valorem tariffs, with India ...

Pharma sector stocks such as Sun Pharma, Dr Reddy’s, Cipla, Biocon, Shilpa Medicare, Zydus Life and Hester Bio are in focus ...

Sun Pharma will be responsible for pursuing regulatory approvals in licensed territories where approval has not yet been ...

Sun Pharma secures global rights for the cholesterol drug Lerodalcibep from LIB Therapeutics. Understanding the impact on its ...

Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the ...

Sun Pharmaceutical Industries (SUNPHARMA.NS) announced the commercial availability of Taro-Methylphenidate ER for Canadian patients in Ontario and Quebec. Taro-Methylphenidate ER is the only ...

"Sun Pharma is excited to launch this much-anticipated, osmotic delivery formulation of methylphenidate as a lower-cost ...